Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria
NCT01350752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6513
Last updated 2016-09-09
Summary
The objective of the REACT project is to evaluate the effectiveness and cost-effectiveness implications of interventions designed to improve health worker practice in providing treatment for uncomplicated malaria to febrile patients attending health facilities in Cameroon and Nigeria.
Conditions
Interventions
- BEHAVIORAL
-
RDTs & Provider Training on Malaria Diagnosis and Treatment
In Cameroon and Nigeria, malaria RDTs will be made available in health facilities and health care providers will receive training and job aids on malaria diagnosis and treatment. The training course covers the following topics: clinical and parasitological diagnosis of malaria, how to use a rapid diagnostic test, algorithm based on malaria test result, recommended treatment for confirmed malaria cases (including dosage and regimen for artemisinin-based combination therapies), advice for treatment of test-negative patients
- BEHAVIORAL
-
Extended provider training (Cameroon only)
2-day training course which supplements basic provider training on malaria diagnosis and treatment, which focuses on understanding change in malaria treatment guidelines, professionalism, and communication skills
- BEHAVIORAL
-
School based malaria education (Nigeria only)
Schools will be invited to undertake activities to raise awareness about malaria RDTs and treatment among children and community members. The intervention includes training teachers on peer health education, malaria awareness activities and providing support to hold a malaria educational event
Sponsors & Collaborators
-
University of Yaounde
collaborator OTHER -
University of Nigeria, Enugu Campus
collaborator OTHER -
London School of Hygiene and Tropical Medicine
lead OTHER
Principal Investigators
-
Virginia Wiseman · London School of Hygiene and Tropical Medicine
-
Wilfred Mbacham · University of Yaounde I
-
Obinna Onwujekwe · University of Nigeria
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-09-30
- Completion
- 2015-01-31
Countries
- Cameroon
- Nigeria
Study Locations
More Related Trials
-
Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children
NCT01082705 ·Status: COMPLETED ·Phase: PHASE3
-
Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packs
NCT01065116 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon
NCT05340153 ·Status: UNKNOWN ·Phase: PHASE4
-
Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda
NCT04037332 ·Status: COMPLETED
-
Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia
NCT04241705 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya
NCT01899820 ·Status: UNKNOWN ·Phase: PHASE3
-
Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children
NCT00406146 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs
NCT00720811 ·Status: COMPLETED ·Phase: NA
-
Artemether-Lumefantrine Effectiveness in Guinea-Bissau
NCT01157689 ·Status: COMPLETED
-
Malaria High-Risk Populations in Namibia
NCT04094727 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo
NCT02940756 ·Status: COMPLETED ·Phase: PHASE4
-
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
NCT01459146 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Trial on Effectiveness of ACTs in Ghana
NCT00374205 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia
NCT06300970 ·Status: COMPLETED ·Phase: PHASE4
-
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
NCT00832754 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Antimalarial Combinations in Uganda
NCT00123552 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria
NCT00140361 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community Level
NCT01907672 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
NCT04618523 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger
NCT01755559 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.
NCT02089841 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children
NCT00393679 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Antimalarials in Uncomplicated Malaria
NCT00203801 ·Status: COMPLETED ·Phase: NA
-
Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission
NCT01575613 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde
NCT04565184 ·Status: COMPLETED ·Phase: PHASE4